Molecular Axiom is a company that specializes in creating medications using nucleic acids to combat cancer and neurodegenerative diseases. Their unique Boundless-LNP delivery system allows them to zero in on specific tissues and cell types, enabling them to develop treatments for lung cancer and neurodegenerative disorders.

Disease Domain	Count

Neoplasms	5
Nervous System Diseases	1

Top 5 Drug Type	Count

ASO	6

Top 5 Target	Count

KRAS G12V(GTPase KRas G12V)	1
SOS1(Son of sevenless homolog 1)	1
KRAS G12D(GTPase KRas G12D)	1
KRAS G12A(KRAS G12A mutation)	1
NLRP1 x NLRP3	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Preclinical

Current Projects

Drug(Targets)	Indications	Global Highest Phase

NLRP3/1(Molecular Axiom) ( NLRP1 x NLRP3 )	Neurodegenerative Diseases More	Preclinical
KRAS G12C(Molecular Axiom) ( KRAS G12C )	Lung Cancer More	Preclinical
KRAS G12D(Molecular Axiom) ( KRAS G12D )	Lung Cancer More	Preclinical
KRAS G12A(Molecular Axiom) ( KRAS G12A )	Lung Cancer More	Preclinical
KRAS G12V(Molecular Axiom) ( KRAS G12V )	Lung Cancer More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis